Marksans Pharma received UK regulatory approval to market a Metformin Hydrochloride oral solution for type 2 diabetes, addressing patients with swallowing difficulties. This expands their generic pharmaceutical portfolio globally.
Atul Auto July Sales Up 11% YoY
Markets Slip as Trump Slaps Tariffs on India
CERA Q1 Profit Slips, Strategy Expands
Vinati Organics Reports Fatal Accident
JTL Profit Falls Despite Higher Sales
Paras Defence Wins Rs 141.63 cr TIFCS Order
Nayara Ships First Gasoline Cargo Post-EU Ban
News that matters the most ⚡